paragon GmbH & Co. KGaA (PGN)
XETRA Stock Exchange · Germany · prices in EUR · close of 16 Oct 2026
Key indicators
| Last close | EUR 0.614 |
|---|---|
| 52-week range | 0.400 – 2.870 |
| Return, 1 month / 3 months | −38.5% / −61.3% |
| Return, 1 year / 3 years | −76.1% / −86.3% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 178.1% |
| Worst drawdown (1 year) | -85.1% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Paragon GmbH & Co. KGaA is a German automotive supplier based in Delbrück. It develops and makes electronic and electromechanical components for vehicles, including sensor systems for interior monitoring, air quality and battery management, along with interior trim and plastic parts. Its customers are carmakers and automotive suppliers, mainly in Europe, who fit these parts into passenger vehicles and commercial vehicles. The company works across automotive electronics and interior components, supplying parts for new vehicle production.
paragon GmbH & Co. KGaA trades under the code PGN on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
paragon GmbH & Co. KGaA (PGN) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 0.614 on 16 October 2026.
Its price-based Market X-Ray is 4 out of 100 (a weak price profile), ranking 694 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 76.1% and over the last three months it fell 61.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 3 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -61.5% | ||
| From 52-week high | -77.2% | ||
| Momentum | 2 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -61.3% | ||
| 6-month return | -64.8% | ||
| 12-month return, skipping the last month | -61.2% | ||
| Stability (higher is calmer) | 2 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 178.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -85.1% | ||
| Liquidity | 12 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −13.0% |
|---|---|
| 1 month | −38.5% |
| 3 months | −61.3% |
| 6 months | −64.8% |
| 1 year | −76.1% |
| 3 years | −86.3% |
| 5 years | −92.4% |
Signals
| 50-day / 200-day average | 1.113 / 1.593 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.157 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 May 2019 | EUR 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.